E2 ModerateModerate confidencePEM not requiredCross-SectionalPeer-reviewedReviewed
The economic impact of chronic fatigue syndrome.
Lloyd, A R, Pender, H · The Medical journal of Australia · 1992
Quick Summary
This study looked at how much money ME/CFS costs—not just for patients themselves, but for the healthcare system and society overall. Researchers surveyed 42 patients in one Australian region about their medical expenses and lost income, then used those numbers to estimate what ME/CFS might cost across all of Australia. They found the disease creates a huge financial burden that had been largely overlooked by policymakers.
Why It Matters
This was one of the first studies to systematically document the true economic cost of ME/CFS, providing evidence that the disease represents a substantial public health burden. By quantifying both direct and indirect costs, it helped establish that ME/CFS deserves serious attention from health economists and policymakers, not just clinicians.
Observed Findings
- In the Richmond Valley region, ME/CFS generated approximately $396,000 in annual costs
- With a regional prevalence of 37.1 cases per 100,000 population, extrapolation suggested at least $59 million in annual national costs for Australia
- Both direct healthcare resource utilization and indirect costs (lost income/employment) contributed substantially to the total economic burden
- ME/CFS represented a large but underrecognized area of health resource use
Inferred Conclusions
- ME/CFS produces a substantial economic burden on individuals, government, and communities that had been significantly underestimated
- The disorder warrants greater recognition as a public health priority given its financial impact
- Economic data should inform health policy and resource allocation for ME/CFS research and management
Remaining Questions
- How do costs vary across different geographic regions and healthcare systems, and how reliable is extrapolation from a single rural area?
- What proportion of the economic burden is attributable to direct medical care versus lost productivity, and how does this change with disease severity?
- Has the economic impact of ME/CFS changed in the decades since 1992, and how do current estimates compare internationally?
What This Study Does Not Prove
This study does not establish the causes of ME/CFS or prove that the disease itself directly causes all measured economic losses—confounding factors, healthcare-seeking behaviors, and diagnostic accuracy could all influence the results. The extrapolation from one rural region to the entire Australian population involves significant assumptions that may not hold across different geographic and demographic areas.
Tags
Symptom:Fatigue
Method Flag:Weak Case DefinitionSmall SampleNo ControlsExploratory Only
Metadata
- PMID
- 1406420
- Review status
- Editor reviewed
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.